Genetic and molecular testing for solid organ transplantation — Coverage criteria
Customize your policy alerts
Sign up for all Community Health Plan Washington policy alerts
Know when Community Health Plan Washington releases new policies or updates existing guidance.
Monitor payer policy activity
Criteria and coding guidance for use of genetic and molecular laboratory tests (e.g., donor-derived cell-free DNA, gene expression panels, HLA typing) in the evaluation and management of solid organ transplant candidates and recipients.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.